Extrait

To assess the pharmacokinetics of doripenem after a single 30 mg/kg doripenem 4-hour i.v. infusion administered to pediatric subjects 6 to 17 years of age, inclusive, with cystic fibrosis (CF). Safety and tolerability will also be assessed.

Critère d'inclusion

• Cystic fibrosis

Liens

• euctr